Related references
Note: Only part of the references are listed.Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample
Mina Suh et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age
Naimisha Movva et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
The ongoing impact of COVID-19 on asthma and pediatric emergency health-seeking behavior in the Bronx, an epicenter
Rachel Levene et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)
The COVID-19 Pandemic and Changes in Healthcare Utilization for Pediatric Respiratory and Nonrespiratory Illnesses in the United States
James W. Antoon et al.
JOURNAL OF HOSPITAL MEDICINE (2021)
Navigating Through Health Care Data Disrupted by the COVID-19 Pandemic
Kayoko Shioda et al.
JAMA INTERNAL MEDICINE (2020)
Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012
Abigail Doucette et al.
PLOS ONE (2016)
Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
Michael T. Brady et al.
PEDIATRICS (2014)
National disease burden of respiratory viruses detected in children by polymerase chain reaction
KJ Henrickson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)